电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

CEP290 抗体 (AA 2429-2479)

CEP290 适用: 人 IF/ICC 宿主: 兔 Polyclonal unconjugated
产品编号 ABIN7448387
发货至: 中国
  • 抗原 See all CEP290 抗体
    CEP290 (Centrosomal Protein 290kDa (CEP290))
    抗原表位
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 2429-2479
    适用
    • 27
    • 8
    • 3
    • 1
    • 1
    宿主
    • 25
    • 2
    克隆类型
    • 27
    多克隆
    标记
    • 17
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This CEP290 antibody is un-conjugated
    应用范围
    • 14
    • 13
    • 6
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    Immunofluorescence (fixed cells) (IF/ICC)
    原理
    Rabbit anti-CEP290 IHC Antibody, affinity purified
    预测反应
    Horse,Orangutan,Monkey,Gorilla,Northern white-cheeked gibbon,Small-eared galago,African elephant
    纯化方法
    Affinity Purified
    免疫原
    Between AA 2429 and 2479
    亚型
    IgG
    Top Product
    Discover our top product CEP290 Primary Antibody
  • 应用备注
    1:100 - 1:500
    限制
    仅限研究用
  • 浓度
    500 μg/mL
    缓冲液
    Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
    储存液
    Sodium azide
    注意事项
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    储存条件
    4 °C
    有效期
    12 months
  • 抗原
    CEP290 (Centrosomal Protein 290kDa (CEP290))
    别名
    CEP290 (CEP290 产品)
    背景
    Background: Centrosomal protein 290 (CEP290) is a member of the nephrocystins, a family of proteins involved in renal cystic diseases. CEP290 and the nephrocystins appear to play a role in cilia and basal body function. Loss-of-function mutations in CEP290 result in Joubert syndrome and related disorders characterized by brain malformations, developmental delay, ataxia, irregular breathing, renal disease, and hepatic fibrosis.
    基因ID
    80184
    NCBI登录号
    NP_079390
    UniProt
    O15078
    途径
    cAMP Metabolic Process, M Phase
You are here:
Chat with us!